Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite to seamlessly integrate applications across imagin...
01 Diciembre 2019 - 9:00AM
Philips extends AI portfolio with launch of IntelliSpace AI
Workflow Suite to seamlessly integrate applications across imaging
workflows
December 1, 2019
Comprehensive platform launching with an ecosystem of
applications from partners including Aidoc, MaxQ AI, Quibim,
Riverain Technologies and Zebra Medical
Chicago, U.S. and Amsterdam, the Netherlands
– Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology, today announced the launch of
IntelliSpace AI Workflow Suite [1] to enable healthcare providers
to seamlessly integrate AI applications into the imaging workflow.
Part of Philips’ new enterprise imaging informatics solution, the
comprehensive AI workflow platform provides a full suite of
applications for integration and centralized workflow management of
AI algorithms, delivering structured results wherever they’re
needed across the healthcare enterprise. Partners at launch include
Aidoc, MaxQ AI, Quibim [2], Riverain Technologies and Zebra
Medical.
IntelliSpace AI Workflow Suite is being unveiled at the 2019
Radiological Society of North America Annual Meeting (RSNA). Leiden
University Medical Center (LUMC) in the Netherlands recently signed
an agreement to be the first healthcare provider to install the
platform.
A comprehensive solution that seamlessly integrates with
existing workflowsIntegrating into existing department and
hospital infrastructure, the suite automatically orchestrates the
routing of clinical data to the appropriate AI application within
the healthcare provider’s ecosystem to allow data analysis without
user interaction, and displays the results. The suite is designed
to support Philips’ commitment to providing open, comprehensive
solutions to healthcare providers’ AI imaging needs. Natively
integrating with Philips’ diagnostic imaging and informatics
solutions, IntelliSpace AI Workflow Suite can also be used
alongside imaging solutions from other vendors. In addition, the
suite is designed to support the training of site-specific AI
applications based on local data.
Philips recognized for AI leadershipPhilips was
recently recognized by Frost & Sullivan as Company of the Year
for Artificial Intelligence for Enhanced Radiology Interpretation,
thanks to the company’s approach to imaging AI as a disruptive
imaging informatics strategy. Recognized for AI combining with deep
knowledge of the clinical and operational context in which it is
used, Philips is embedding AI within imaging workflows across
multiple touchpoints to better personalize the patient care
pathway.
“AI is already supporting clinical decision-making and
increasing efficiency in imaging departments,” said Calum
Cunningham, General Manager Enterprise Diagnostic Informatics at
Philips. “Philips is among the top three companies in the world in
terms of AI-related patent applications in healthcare. With the
IntelliSpace AI Workflow Suite we’re enabling healthcare providers
to take a comprehensive, future-proof approach to integrating AI
applications that maximizes their benefits while ensuring seamless
integration into existing workflows.”
AI-enabled imaging applications and AI algorithms are playing an
important role in achieving the ‘quadruple aim’ in healthcare:
better health outcomes, lower cost of care, and an improved
experience for patients and staff. As the number of applications
and vendors increases, healthcare providers risk being overwhelmed
by technical integration challenges as well as administrative
overhead. By seamlessly integrating AI applications from Philips’
partners, the Philips IntelliSpace AI Workflow Suite enables
healthcare providers to capitalize on the latest AI applications,
increase diagnostic confidence and efficiency without adding
complexity.
Philips IntelliSpace AI Workflow Suite is launching with
applications including:
- Aidoc: applications including
intracranial hemorrhage, C-spine fractures, and pulmonary
embolism
- MaxQ AI: applications
including the company’s ACCIPIO® intracranial hemorrhage and stroke
platform
- Quibim: applications
including brain lesions detection, chest X-ray classifier,
emphysema, liver fat and iron concentration, and brain atrophy
analysis [2]
- Riverain Technologies:
applications including the company’s ClearRead bone suppression and
ClearRead CT
- Zebra Medical: applications
including intracranial hemorrhage and pneumothorax
Part of Philips’ next-generation enterprise imaging
informatics solution IntelliSpace AI Workflow Suite is
part of Philips’ next-generation enterprise imaging informatics
solution. The introduction follows several years of strategic
investments in R&D, AI and complementary acquisitions,
resulting in a suite of integrated products that deliver a
comprehensive platform designed to connect clinical capabilities
and optimize workflows around every step in the patient’s
journey.
Philips is demonstrating its imaging solutions at the 2019
Radiological Society of North America (RSNA) Annual Meeting in
booth #6730. In addition to its main presence (booth #6730),
Philips will also have a strong presence in the AI Showcase hall
(North Hall Level 1, booth #10109). For more information about
Philips’ presence at RSNA, including its program of live talks on a
range of topics including AI in radiology, visit
www.philips.com/RSNA, and follow @PhilipsLiveFrom for #RSNA19 live
updates.
[1] IntelliSpace AI Workflow Suite is not intended for diagnosis
or treatment selection. Work in progress, not available for
sale.[2] Applications from Quibim are not 510(k) cleared and not
available for sale in the USA.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916Email: mark.groves@philips.comTwitter: @mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 80,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- IntelliSpace_AI_Workflow_Suite
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024